| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |